Cite

    Ryan, A., Polycarpou, E., Lack, N. A., Evangelopoulos, D., Sieg, C., Halman, A., Bhakta, S., Eleftheriadou, O., McHugh, T. D., Keany, S., Lowe, E. D., Ballet, R., Abuhammad, A., Jacobs, W. R., Ciulli, A., & Sim, E. (2017). investigation of the mycobacterial enzyme HsaD as a potential novel target for anti‐tubercular agents using a fragment‐based drug design approach. British journal of pharmacology, 174, 2209–2224. http://access.bl.uk/ark:/81055/vdc_100047416130.0x000062